Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102603570A reveals a novel one-step ionic liquid cyanation method. Achieve significant cost reduction in pharma intermediates manufacturing with high purity.
Patent CN103351333A details a high-yield Suzuki coupling method for aryl pyridine derivatives, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN1232519C details advanced Pd-catalyzed amination for high-purity benzofuran intermediates, offering significant supply chain and cost advantages.
Patent CN103130632A reveals novel tubulin inhibitors for leukemia. Discover cost-effective manufacturing and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN1227250C reveals a safer, scalable route for CDK inhibitor intermediates, eliminating hazardous diazo compounds and chromatography for cost-effective manufacturing.
Patent CN1774430A details a novel sulfolane-based cyclopropanation for taxane intermediates, offering improved purity and scalable manufacturing for API production.
Patent CN1479742A details the first chemical synthesis of anticancer GM-95. Discover scalable routes, cost reduction strategies, and supply chain advantages for pharmaceutical manufacturing.
Patent CN102285991A details an acid-assisted acetone/water refining method for Temozolomide, achieving over 99.5% purity with significant cost and supply chain advantages.
Patent CN118459469A details a novel Mitsunobu route for Ibrutinib. Achieves 99.95% purity with water-soluble byproducts, ensuring cost reduction and supply reliability.
Patent CN108349980A details a biphasic acylation method for ibrutinib, offering significant supply chain efficiency and cost reduction advantages for pharmaceutical manufacturing.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN112125942A reveals a novel chlorination route for Abiraterone Acetate intermediates, offering higher purity and yield compared to traditional iodination methods for scalable manufacturing.
Patent CN1989148A reveals a solid-state synthesis route for 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose, enabling scalable Gemcitabine production with superior purity.
Patent CN110790713A reveals a low-temperature route for high-purity 2-hydroxyquinoxalines, offering significant cost reduction in API manufacturing and simplified supply chains.
Discover the novel preparation method for Pemetrexed Diacid via CN103254196A. This route eliminates palladium catalysts and nitro groups, offering significant cost reduction and supply chain reliability for oncology API manufacturing.
Advanced synthesis method for high-purity Ibrutinib via controlled acylation. Reduces Impurity V, ensures >99% purity, and offers scalable manufacturing solutions.
Discover a novel semi-synthetic method for Paclitaxel and Docetaxel via stereochemical inversion. High-yield, scalable process for reliable pharmaceutical intermediate supply.
Novel semi-synthesis of paclitaxel and docetaxel using trans-chiral side chains and stereochemical inversion. High yield, industrial scale potential.
Patent CN101805323B details a safer, scalable route for Doranidazole intermediates using diethyl tartrate, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN1829722A details a regioselective boronate route for CCI-779, eliminating chromatography for cost-effective API intermediate manufacturing.